Reh cells, 24 hours c-Myc Ac-p53 b-actin

Slides:

Advertisements

Similar presentations

Supplementary Figure 1. Caspase 8 expression and activation and Fas expression in NSCLC and normal lung cell lines. A Western blot analysis of DR4 and.

Advertisements

Supplemental figure 1 ROS production in MM cell line (KMM1) treated with bortezomib and DCA. ROS production was marginally increased by DCA in combination.

Supplemental Figure 1 A No. at risk T T T

Supplemental Figure 1. Supplemental Figure 2 Supplemental Figure 3 A B.

P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

H1299 Vector H1648 TUSC2 TUSC2 -ER 2.3 uM ER H1299 Vector TUSC2 TUSC2 -ER 2.3 uM ER H1299 Vector H1648 TUSC2 TUSC2 -ER 2.3 uM ER H1299 Vector TUSC2 TUSC2.

The Cell Division Cycle

Supplemental Figure cells/ well DLD-1 ALDH+/CD133+ DLD-1 ALDH- /CD133- Supplemental Figure 2.

Supplemental Results Online Figure S1. Norepinephrine increases ROS production. (A): H9c2 cells were treated with 10  M norepinephrine and intracellular.

Cell Biology. Outline Organization of body systems – Organ – Tissue – Cell— How do we study biology? – Why should we? Research question in biology.

D Day 2Day 1Day 4Day 6 Day 1 Day 2 Day 4 Day 6 Biopsy Injury D0 D1 D2 D3 D4 D5 D6 Wound monitoring by endoscope & Intrarectal adminstration of LGG or HBSS.

Supplementary Table S1 Clinical exposure for palbociclib, fulvestrant and chemotherapeutic agents used in this study. Palbociclib (1)*Paclitaxel (2)*Doxorubicin.

Supplemental Figure S1 ResidueMass Delta Mass Sequence Mascot Ion Score R.DFGLLVFVR.K K.IPALDLLIK.L K.FYGELALK.K34.

Supplemental Figure 1. A. GCN1L1B. DSPC. RCN3 D. AKR1B10E. PDIA4F. CTSB.

A B Figure S1 (related to Figure 1). BETi-tolerant A375 and NOMO-1 cells show an abrogated apoptotic response to BETi. C D E F.

Farmer et al Supplementary Figure 1 KU PARP-1 IC 50 = 3.2nM KU PARP-1 IC 50 = 3.4nM KU PARP-1 IC 50 = 730nM a b

Myc Represses Primitive Endoderm Differentiation in Pluripotent Stem Cells Keriayn N. Smith, Amar M. Singh, Stephen Dalton Cell Stem Cell Volume 7, Issue.

Figure1 HER2 SKBr3 PC3 A. SKBr3 cells Figure (µM) Penetratin control % of control (µM)

Figure Molecular Biology of the Cell (© Garland Science 2008)

Figure 14-1 Molecular Biology of the Cell (© Garland Science 2008)

Shimura Supplemental Figure 1

Invest. Ophthalmol. Vis. Sci ;47(1): doi: /iovs Figure Legend:

a c b S1. Lee et al., 2011 * RRT-binding PXDLS-binding NAD(H)-binding

Figure 3. Synergistic effects of the combination of trabectedin and olaparib on poly(ADP-ribosyl)ation and DNA damage in four different breast cancer cell.

Progesterone receptor

Figure 3. Elevation of p53 and its acetylation after treatment with FK866 and nicotinamide adenine dinucleotide (NAD+). Cells were treated for 72 hours.

by Roel Polak, Bob de Rooij, Rob Pieters, and Monique L. den Boer

A 4 Band intensity (relative unit) MMP-9 MMP-2 B C 4 4

Supplemental Figures Supplemental Figure 1.

10X dilution x ~10nM full – length competitor

A B C Supplemental Figure S1 SET2 HEL BRD4 β-Actin SET2

Supplemental Figure 1 A B C.

A. D. B. C. - ΔNP63α - β-Actin IMEC - SUM MDA-MB IMEC

Supplemental Figure S1 a b

Supplemental Figure S1 B A C D.

Supplementary Figure 1 Negative control IC50 110 mM (acetate)

BET inhibition and depletion repress the expression of BRCA1 and RAD51

Supplemental Figure S2: G2 arrest in MCF7-shPBK1 stable cell line

a b MCF-7 TR2 MCF-7 TR2 (Fold change) MTT Assay , (Fold change)

Supplementary Figure S2

Supplement Figure 3 SYF cells

Supplemental Figure 1A – I

A B CDK2 CDK2 inhibition P Activated KRAS P CP110 CP110

pIRS1(S636/639) IRS1 actin PF Supplemental Figure S1

B A D C * * E F Panc-1 cells Figure S1 DNA ladder h

PTB1 nPTB Ai Aii GM03201 P1+N1 GM2132 P1+N1 GM2132 C1 GM2132 P1

Supplement Figure 2 HEK 293 cells

500 nm WRITE VOLTAGE 0 V.

Supplemental Figure 5 v A Idarubicin 100 nM Idarubicin 300 nM B C D

Supplemental Figure 1A Pt Pt Pre-treatment

Supplemental Figure 1 a b c d.

Supplementary Figure 1 HCT116 MOLT4

Supplemental Figure 1 Patient 2.

Supplementary Figure S4

20S proteasome activities

Experimental validation of predicted endocytosis functions in human.

Supplemental Figure 1A SMM Patient #1 MP-CTL % CD3+ CD8+ T Cells

Figure S3. Zhang et al. A B Myc-SIRT1 - + sir2a+/+ sir2a-/-

Supplementary Figure S1

Induction of apoptosis by nelfinavir and bortezomib

USP2a regulates MYC expression through the MDM2–p53 axis.

Supplemental Figure 1 Cell proliferation (% of mock)

Inhibition of polymerization Enhancement of polymerization

Platinum-based chemotherapy increased TXNIP expression, and overexpression of TXNIP enhanced the effectiveness of this therapy. Platinum-based chemotherapy.

BCG uptake by bladder cancer cells requires activated Pak1.

e a b c d unstimulated +fMLP T308P-Akt S473P-Akt Akt (min)

Figure 5-1 Molecular Biology of the Cell (© Garland Science 2008)

Presentation transcript:

Reh cells, 24 hours c-Myc Ac-p53 b-actin 0 1 5 10 0 0 1 5 1 SRT2183, uM 0 0 0 0 10 20 10 10 20 pano, nM c-Myc Ac-p53 b-actin SUPPLEMENTAL FIGURE 3

NALM-6 cells, 24 hours c-Myc Ac-p53 b-actin 0 1 5 10 0 0 1 5 1 0 1 5 10 0 0 1 5 1 0 0 0 0 10 20 10 10 20 SRT2183, uM pano, nM c-Myc Ac-p53 b-actin SUPPLEMENTAL FIGURE 3

MOLT-4 cells, 24 hours c-Myc P-H2A.X Ac-H4 (K8) b-actin 0 5 10 0 0 5 10 5 SRT2183, uM 0 0 0 10 20 10 10 20 pano, nM c-Myc P-H2A.X Ac-H4 (K8) b-actin SUPPLEMENTAL FIGURE 3